M&A Deal Summary |
|
---|---|
Date | 2017-04-20 |
Target | Upsher-Smith Laboratories - Generics Business |
Sector | Life Science |
Buyer(s) | Sawai Pharmaceutical |
Sellers(s) | Upsher-Smith Laboratories |
Deal Type | Divestiture |
Deal Value | 1.1B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Sawai Pharmaceutical Co. Ltd. is a generic pharmaceuticals manufacturer. Sawai Pharmaceutical was founded in 1929 and is based in Osaka, Japan.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Minnesota) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2017) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
Category | Company |
---|---|
Founded | 1919 |
Sector | Life Science |
Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 2 of 2 |
State (Minnesota) | 2 of 2 |
Country (United States) | 2 of 2 |
Year (2017) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-12-19 |
AmLactin
Maple Grove, Minnesota, United States AmLactin is a developer, manufacturer of skin care products including therapeutic moisturizers and conditioners. |
Sell | - |